The relationship between heparin level and activated clotting time in the adult cardiac surgery population

The purpose of this descriptive study was to examine the relationship between heparin levels (HL) determined by heparin protamine titration (HPT) and activated clotting time (ACT) for cardiopulmonary bypass (CPB) in an adult cardiac surgery population. We examined institutional databases for all pat...

Full description

Saved in:
Bibliographic Details
Published in:Perfusion 2009-03, Vol.24 (2), p.93-96
Main Authors: FitzGerald, DJ, Patel, A, Body, SC, Garvin, S
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Blood Coagulation - drug effects
Blood Coagulation - physiology
Cardiopulmonary Bypass
Female
Heart Failure - blood
Heart Failure - surgery
Heart Failure - therapy
Heparin - administration & dosage
Heparin - blood
Humans
Male
Middle Aged
Whole Blood Coagulation Time
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The purpose of this descriptive study was to examine the relationship between heparin levels (HL) determined by heparin protamine titration (HPT) and activated clotting time (ACT) for cardiopulmonary bypass (CPB) in an adult cardiac surgery population. We examined institutional databases for all patients who underwent CPB at a single US academic institution from February 2005 until July 2007. Baseline ACT, predicted and actual heparin dose response (HDR), target and actual ACT, heparin concentration and heparin bolus dose were recorded. We examined the ACT and HL after the initial heparin bolus dose (Post-Hep) and 10 minutes after the initiation of CPB (CPB+10). The Post-Hep and CPB+10 ACT and HL are reported for 3802 patients. The distribution of ACTs for HL of 0.7, 1.4, 2.0, 2.7 and 3.4 units heparin/mL blood at both time points are reported. Additional analysis of the relationship of HL to ACTs of 300, 350, 400 and 480 seconds is also presented.
ISSN:0267-6591
1477-111X
DOI:10.1177/0267659109106729